Country Head, CTO, Head of AI Drug Discovery & Leadership Recruitment Across India's Global Pharma, Med-Devices and Biotech GCC Cluster
Pharmaceuticals & Life Sciences GCC
Executive Search
8+ Pharma GCC Leadership Placements — typical mandates close in 100-150 days, with a 12-month candidate guarantee.
Specialisation withinGlobal Capability Centers (GCC)·Country Head, CTO, Head of AI & Leadership Recruitment Across India's 1,750+ Global Capability Centre Cluster
The Pharma & Life Sciences GCC cohort spans 120+ global-pharma, medical-devices, biotech, contract-research-organisation, bioinformatics and life-sciences-data-and-analytics India captives across Hyderabad (the dominant Pharma GCC catchment by headcount), Bengaluru, Pune, Mumbai and Chennai. Aggregate Pharma GCC headcount has crossed 100,000-plus across the cohort, with multi-year capacity-addition anchored by AI drug-discovery deployment, clinical-trial-and-real-world-evidence data-platform modernisation, medical-devices-and-bioinformatics digital-transformation and the broader life-sciences digital-transformation pipeline.
Is This Your Situation?
If any of these sound familiar, you're speaking to the right practice.
→Global pharma India captive scaling from 1,000-engineer to 3,500-engineer appointing a Country Head.
→Global pharma India captive launching an AI drug-discovery capability — Head of AI Drug Discovery appointment.
→Global medical-devices India captive scaling clinical-trial-data-platform — Head of Clinical Trial Data appointment.
→Global biotech India captive launching real-world-evidence capability — Head of Real-World-Evidence appointment.
Our Pharma GCC Track Record
Situation:
A global pharma India captive scaling from 1,000-engineer to 3,500-engineer required a Country Head with multi-MNC Pharma GCC operating credibility, India site-and-engineering-org-scaling discipline and global-parent governance fluency.
Outcome:
Country Head developed and reference-worked across multi-MNC Pharma GCC Country-Head bench. Search ran 130 days; appointed Country Head presented a three-year India-GCC-scaling plan within 90 days.
Situation:
A global pharma India captive launching an AI drug-discovery capability required a Head of AI Drug Discovery with AI-research-and-ML-engineering-talent-acquisition-and-retention architecture credibility, pharma-and-life-sciences AI domain-and-platform credibility and global-parent AI-governance fluency.
Outcome:
Head of AI Drug Discovery developed and reference-worked across global-pharma-AI and applied-AI India-leadership bench. Search ran 100 days; appointed Head of AI Drug Discovery built a 30-AI-researcher org in the first six months.
All client details anonymised. Specific mandates available for reference under NDA upon request.
Our Pharma GCC Practice
The Pharma & Life Sciences GCC cohort spans 120+ global-pharma, medical-devices, biotech, contract-research-organisation, bioinformatics and life-sciences-data-and-analytics India captives across Hyderabad (the dominant Pharma GCC catchment by headcount), Bengaluru, Pune, Mumbai and Chennai. Aggregate Pharma GCC headcount has crossed 100,000-plus across the cohort, with multi-year capacity-addition anchored by AI drug-discovery deployment, clinical-trial-and-real-world-evidence data-platform modernisation, medical-devices-and-bioinformatics digital-transformation and the broader life-sciences digital-transformation pipeline.
We serve the Pharma GCC practice across Country Head / Managing Director / India Site Leader appointments, CTO / Head of Engineering / Head of Bioinformatics appointments, Head of AI / Head of AI Drug Discovery / Head of Clinical Data Science appointments, Head of Data Platforms / Head of Clinical Trial Data appointments, Head of Cybersecurity / CISO appointments, Head of Regulatory Affairs / Head of Quality appointments, CFO / Controller appointments and the full leadership-recruitment-tier.
As a specialist Country Head and Managing Director mandates, our practice also covers CTO and Chief Technology Officer placements, our practice also covers GCC industry practice overview, our practice also covers Pharmaceuticals & Biotech industry practice, and as a source for Healthcare & Life Sciences industry practice.
The Pharma GCC Landscape Today
India's Pharma GCC ecosystem has crossed 120+ centres with aggregate headcount of 100,000-plus across the cohort. Hyderabad is the dominant Pharma GCC catchment (driven by the Hyderabad pharma-and-life-sciences industrial-corridor); Bengaluru, Pune, Mumbai and Chennai together account for the remaining cohort. The Telangana pharma-and-life-sciences GCC investment policy, the Karnataka digital-economy ecosystem and the Maharashtra and Tamil Nadu pharma-and-life-sciences GCC investment policies together shape the bench. Country Head, CTO, Head of AI Drug Discovery and Head of Bioinformatics compensation has materially re-rated.
Key Leadership Challenges in Pharma GCC
Country Head / Managing Director / India Site Leader appointments at Pharma GCCs.
CTO / Head of Engineering / Head of Bioinformatics appointments at Pharma GCC scale.
Head of AI / Head of AI Drug Discovery / Head of Clinical Data Science appointments — pharma-and-life-sciences AI deployment is the differentiator.
Head of Data Platforms / Head of Clinical Trial Data / Head of Real-World-Evidence appointments.
Head of Cybersecurity / CISO appointments — pharma-customer-cybersecurity-and-data-protection discipline.
Head of Regulatory Affairs / Head of Quality appointments — multi-jurisdiction regulatory-and-quality discipline.
What We Look For in Pharma GCC Leaders
Across mandates, pharma gcc leadership tends to cluster into a small set of archetypes. We calibrate each search against the profile your board actually needs — not the one most commonly available.
The Pharma GCC Country Head
Executive who has led a global-MNC India Pharma GCC at Country Head / Managing Director / India Site Leader level — fluent in multi-MNC Pharma GCC operating credibility, India site-and-engineering-org-scaling discipline and global-parent governance fluency.
The Pharma GCC CTO / Head of Bioinformatics
CTO / Head of Bioinformatics who has led a Pharma GCC engineering-and-bioinformatics-org at scale — fluent in pharma-and-life-sciences engineering-and-bioinformatics architecture and engineering-and-bioinformatics-talent-acquisition-and-retention architecture.
The Pharma GCC Head of AI Drug Discovery
Head of AI Drug Discovery who has led an AI drug-discovery platform — fluent in AI-research-and-ML-engineering-talent-acquisition-and-retention architecture, pharma-and-life-sciences AI domain-and-platform credibility and global-parent AI-governance fluency.
The Pharma GCC Head of Clinical Trial Data
Head of Clinical Trial Data / Head of Real-World-Evidence who has led a clinical-trial-data-platform — fluent in clinical-trial-data-platform-and-architecture credibility and pharma-clinical-regulatory-compliance interface.
The Pharma GCC CISO
CISO who has led a Pharma GCC security-org — fluent in pharma-customer-cybersecurity-and-data-protection discipline credibility and DPDP Act 2023 regulatory-compliance interface.
Regulatory & Compensation Context
Regulatory Backdrop
Pharma GCC leadership operates within a multi-jurisdiction compliance envelope. The Indian Companies Act 2013 governs Indian-statutory architecture. The DPDP Act 2023 governs personal-data protection. The Drugs and Cosmetics Act 1940 and the Central Drugs Standard Control Organisation (CDSCO) frameworks govern pharma-and-life-sciences regulatory architecture. The US FDA, EMA, MHRA and global pharma-regulatory frameworks (where applicable) govern global-parent pharma-regulatory architecture. The HIPAA architecture applies for US-pharma-customer-data-handling. The MeitY GCC policy framework governs preferential GCC treatment. The Foreign Exchange Management Act and DPIIT FDI rules govern global-parent investment.
Compensation Architecture
Pharma GCC leadership compensation operates at globally-benchmarked architecture. Country Head packages typically land ₹5-13 crore fixed cash (frequently dollar-denominated), 60-120% short-term incentive in performance shares of the global parent, plus multi-year RSU vesting on global parent stock. CTO / Head of Bioinformatics packages command ₹3.5-8 crore fixed cash with global-parent RSU vesting. Head of AI / Head of AI Drug Discovery packages command ₹3-9 crore fixed cash and are rapidly re-rating. Head of Clinical Trial Data / Head of Real-World-Evidence packages command ₹2.5-6 crore fixed cash. Head of Cybersecurity / CISO packages command ₹2-5 crore fixed cash. Leadership-recruitment-tier VP-and-Director-level packages typically land ₹1-3 crore fixed cash.
Roles We Typically Place
Why Gladwin International Leadership Advisors for Pharma GCC
Country Head / Managing Director / India Site Leader appointments at Pharma GCCs.
CTO / Head of Engineering / Head of Bioinformatics appointments at Pharma GCC scale.
Head of AI / Head of AI Drug Discovery / Head of Clinical Data Science appointments.
Head of Data Platforms / Head of Clinical Trial Data / Head of Real-World-Evidence appointments.
Head of Cybersecurity / CISO appointments at Pharma GCCs.
Head of Regulatory Affairs / Head of Quality appointments.
VP-and-Director-tier and senior-leadership-tier appointments.
CFO / Controller / Head of Finance appointments with Pharma GCC finance-architecture credibility.
Organisations We Serve
Global pharma India captives (innovator, generics, specialty)
Global medical-devices India captives
Global biotech India captives
Global contract-research-organisation (CRO) India captives
Global bioinformatics-and-life-sciences-data India captives
Global animal-health and consumer-health India captives
Parent Practice
Return to Global Capability Centers (GCC)
Discuss a Pharma GCC Mandate
Confidential · No obligation
Response within 4 business hours · All enquiries handled by a senior practice partner · Strictly confidential